Biofil Chemicals Quarterly Results for Trading Insights
BIOFILCHEM • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Biofil Chemicals Quarterly Results Key Highlights
- Revenue of ₹34 Cr in March 2025 (+0.0% vs March 2025, -17.1% vs March 2024)
- Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
- EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 3.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹0.34 in March 2025 (+0.0% vs March 2025)
Biofil Chemicals Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 46 | 34 | 41 | 30 | 23 | 35.3% | - |
| Net Profit (₹ Cr) | 3 | 1 | 1 | 1 | 1 | - | - |
| EBITDA (₹ Cr) | 4 | 1 | 1 | 1 | 2 | - | - |
| EPS (₹) | 1.80 | 0.34 | 0.44 | 0.34 | 0.44 | - | - |
| Operating Margin (%) | 1.0% | 3.0% | 2.0% | 4.0% | 6.0% | - | - |
Biofil Chemicals Share Price Trend Around Quarterly Results
Visualize Biofil Chemicals's 1-year price movement across quarterly results — ideal for logging trades in Biofil Chemicals share price
chart using Tickjournal. All values in ₹.
Related Pages for Biofil Chemicals
Additional stock information and data for BIOFILCHEM
Revenue Trend (₹ Cr)
March 2023
30
March 2024
41
March 2025
34
2026
46
Net Profit Trend (₹ Cr)
March 2023
1
March 2024
1
March 2025
1
2026
3
Operating Margin Trend (%)
March 2023
4.0%
March 2024
2.0%
March 2025
3.0%
2026
1.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Biofil Chemicals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹411,461.95 Cr | 1697.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 130.6 |
|
Divis Laboratories
Sept 2025 |
₹163,940.12 Cr | 6168.5 | 2,860 | 689 | +7.1% | - | 24.1% | 237.5 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹138,072.20 Cr | 4078.0 | 3,219 | 591 | +11.3% | - | 18.4% | 232.5 |
|
Cipla
Sept 2025 |
₹109,041.12 Cr | 1331.5 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,407.02 Cr | 1268.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.4 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores